Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Shares Outstanding (Weighted Average) (2016 - 2025)

Assembly Biosciences (ASMB) has 11 years of Shares Outstanding (Weighted Average) data on record, last reported at $12.7 million in Q3 2025.

  • For Q3 2025, Shares Outstanding (Weighted Average) rose 99.74% year-over-year to $12.7 million; the TTM value through Sep 2025 reached $12.7 million, up 99.74%, while the annual FY2024 figure was $6.0 million, 31.18% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $12.7 million in Q3 2025 per ASMB's latest filing, up from $7.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $48.3 million in Q3 2022 and bottomed at $4.0 million in Q4 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $20.2 million, with a median of $7.5 million recorded in 2025.
  • Peak YoY movement for Shares Outstanding (Weighted Average): crashed 91.17% in 2023, then soared 99.74% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $43.3 million in 2021, then plummeted by 90.68% to $4.0 million in 2022, then rose by 13.47% to $4.6 million in 2023, then soared by 31.18% to $6.0 million in 2024, then surged by 111.27% to $12.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $12.7 million in Q3 2025, $7.6 million in Q2 2025, and $7.5 million in Q1 2025.